Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Sympathetic activation in ischemic heart disease can cause lethal arrhythmias. These often are preceded by premature ventricular complexes (PVCs), which at the cellular level could result from delayed afterdepolarizations.
Objective: The purpose of this study was to identify and map vulnerable areas for arrhythmia initiation after myocardial infarction (MI) and to explore the link between PVCs and cellular events.
Methods: Anterior-septal wall MI was induced by 120 minutes of coronary occlusion followed by reperfusion (27 MI and 16 sham pigs). After 4 weeks, EnSite™ electroanatomic mapping combined with imaging was performed to precisely locate PVC sites of origin and subsequently record monophasic action potentials. Cardiomyocytes were isolated from different regions to study regional cellular remodeling. Isoproterenol was used as a surrogate for adrenergic stimulation both in vivo and in cardiomyocytes.
Results: PVCs originated from the MI border zone (BZ) and occurred at discrete areas with clusters of PVCs within the BZ. At these sites, frequent delayed afterdepolarizations and occasional associated spontaneous action potentials translating to a PVC were present. Cardiomyocytes isolated from the MI BZ exhibited more spontaneous action potentials than cardiomyocytes from remote regions. Sensitivity to adrenergic stimulation was increased in MI, in vivo and in cardiomyocytes. In awake, freely moving MI animals, frequent PVCs, ventricular arrhythmia, and sudden cardiac death occurred spontaneously at moderately elevated heart rates.
Conclusion: Post-MI, arrhythmias initiate from discrete vulnerable areas within the BZ, where delayed afterdepolarizations, related to increased adrenergic response of BZ cardiomyocytes, can generate PVCs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.hrthm.2021.07.067 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Resistin-like molecule γ attacks cardiomyocyte membranes and promotes ventricular tachycardia.
Science
September 2025
Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Ventricular tachycardia disrupts the heart's coordinated pump function, leading to sudden cardiac death. Neutrophils, which are recruited in high numbers to the ischemic myocardium, promote these arrhythmias. Comparing neutrophils with macrophages, we found that resistin-like molecule γ ( or RELMγ) was the most differentially expressed gene in mouse infarcts.
View Article and Find Full Text PDFMechanistic Insights into Sex Differences in Atrial Electrophysiology and Arrhythmia Vulnerability through Sex-specific Computational Models.
bioRxiv
August 2025
Department of Pharmacology, University of California Davis, Davis, California, United States.
Atrial fibrillation (AF), the most common cardiac arrhythmia, is characterized by notable sex differences in clinical presentation, treatment response, and outcomes. Although prevalence is similar between sexes, women often experience more severe symptoms, higher rates of adverse drug effects, and reduced treatment efficacy. To investigate the underlying sex-specific AF mechanisms, we developed and validated male and female human atrial cardiomyocyte models that integrate known sex-based differences in electrophysiology and calcium (Ca) handling under normal sinus rhythm (nSR) and chronic AF (cAF) conditions.
View Article and Find Full Text PDFNon-invasive action potential recordings using printed electrolyte-gated polymer field-effect transistors.
Nat Commun
August 2025
Center for Nano Science and Technology, Istituto Italiano di Tecnologia, Milano, Italy.
Scalable and high-throughput platforms to non-invasively record the Action Potentials (APs) of excitable cells are highly demanded to accelerate disease diagnosis and drug discovery. AP recordings are typically achieved with the invasive and low-throughput patch clamp technique. Non-invasive alternatives like planar multielectrode arrays cannot record APs without membrane poration, preventing accurate measurements of disease states and drug effects.
View Article and Find Full Text PDFMyocardial cGMP-PKG1α dysregulation contributes to ventricular tachycardia pathogenesis in type II diabetes and metabolic syndrome.
Heart Rhythm
August 2025
Molecular Cardiology Research Institute, Tufts Medical Center; Tufts University School of Medicine, Boston, MA; Tufts Medical Center, Department of Medicine; Division of Cardiology, Department of Medicine, Tufts Medical Center. Electronic address:
Background: Type-II diabetes (DMII) and metabolic syndrome (MBS) increase ventricular arrhythmia and sudden cardiac death risk.
Objectives: Identify mechanisms through which DMII and MBS promote ventricular tachycardia (VT).
Methods: We performed programmed ventricular stimulation (PVS) on leptin receptor mutant (Db/Db) mice with DMII, high fat high sucrose (HFHS)-fed mice with MBS, and cGMP-dependent Protein Kinase 1α (PKG1α) leucine zipper mutant (LZM) mice, which have neither DMII nor MBS but have disrupted PKG1α signaling.
Neuropeptide Y drives ventricular arrhythmogenesis in chronic ischemic heart failure via calcium mishandling.
Heart Rhythm
August 2025
Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Background: Ventricular arrhythmias (VAs) in chronic ischemic heart failure (HF) are associated with high mortality and often refractory to beta-blocker treatment, highlighting the need for alternative therapeutic targets.
Objective: This study investigates the role of neuropeptide Y (NPY), a neurotransmitter released during sympathoexcitation, in the pathogenesis of VAs associated with ischemic chronic HF following myocardial infarction (MI).
Methods: Using a mouse model of ischemic chronic HF after coronary ligation, we employed biochemical, electrophysiological, and calcium ion (Ca) imaging analyses to investigate the proarrhythmic mechanisms of NPY.